0001104659-22-024841.txt : 20220217 0001104659-22-024841.hdr.sgml : 20220217 20220217192656 ACCESSION NUMBER: 0001104659-22-024841 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220215 FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kalkofen Donald A. CENTRAL INDEX KEY: 0001771066 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 22650298 MAIL ADDRESS: STREET 1: 7707 GATEWAY BOULEVARD, SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980505495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 BUSINESS PHONE: (510) 474-0170 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 4 1 tm227111-4_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-02-15 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001771066 Kalkofen Donald A. 7707 GATEWAY BOULEVARD, SUITE 140 NEWARK CA 94560 0 1 0 0 Chief Financial Officer Common Stock 2022-02-15 4 A 0 7500 0.00 A 18521 D Stock Option (right to buy) 28.73 2022-02-15 4 A 0 45000 0.00 A 2032-02-14 Common Stock 45000 45000 D Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on February 15, 2023, 2024 and 2025. Includes an aggregate of 635 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2021. The stock option vests in 48 equal monthly installments following the date of grant. /s/ Donald A. Kalkofen 2022-02-17